- BETA DRUGS LIMITED
BETA DRUGS LIMITED
NSE: BETA
₹1,770.00
+₹74.95 (4.42%) TodayLast updated on 05 May, 2025 | 15:24 ISTMarket cap  ₹1,711 Crs | Open ₹1,769.00 | Prev. Close ₹1,695.05 |
Circuit range ₹2,034.05 - ₹1,356.05 | Day range ₹1,752.05 - ₹1,785.00 | Year range ₹1,047.65 - ₹2,215.30 |
Volume 2,100 | Avg. traded ₹1,768.97 | Revenue (12m) ₹335 Crs |
About BETA DRUGS LIMITED
Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.
BETA DRUGS LIMITED Share Price Chart
Please wait...
BETA DRUGS LIMITED Fundamentals
BETA DRUGS LIMITED Key indicators
52 week high ₹2,215.30 | 52 week low ₹1,047.65 | P/E ratio 39.74 |
P/B ratio 11.76 | ROE 20.67% | ROCE 27.27% |
Dividend yield -- | Debt/Equity ratio 0.05 | EPS 22.82 |
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
BETA DRUGS LIMITED Financial Ratios
Operating profit margin17.84% | Net profit margin11.1% |
ROE20.67% | ROA14.06% |
ROCE27.27% |
Quick ratio1.92 | Current ratio2.24 |
Interest coverage29.15 | Asset turnover1.27 |
Debt to Equity0.05 |
P/E ratio39.74 | P/B ratio11.76 |
EV / EBITDA33.03 | |
Dividend yield0% |
Revenue statement
All values are in ₹ Crores (Cr)
Loading chart data
Cash flow
All values are in ₹ Crores (Cr)
Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)
No data available at the moment
Total assets
Total liabilities
BETA DRUGS LIMITED Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Fri, May 2 2025 | ₹1,790.20 | ₹1,695.05 | -5.32% |
Wed, Apr 30 2025 | ₹1,770.00 | ₹1,790.20 | -1.49% |
Tue, Apr 29 2025 | ₹1,859.90 | ₹1,817.30 | -1.06% |
Mon, Apr 28 2025 | ₹1,810.00 | ₹1,836.80 | |
Fri, Apr 25 2025 | ₹1,841.55 | ₹1,806.00 | -2.82% |
Thu, Apr 24 2025 | ₹1,842.10 | ₹1,858.35 | |
Wed, Apr 23 2025 | ₹1,899.90 | ₹1,857.05 | |
Tue, Apr 22 2025 | ₹1,911.75 | ₹1,833.45 | -4.10% |
Events
Corporate actions
Bonus • 1:20
Ex date 26 Mar 2025
More
Stocks Similar to BETA DRUGS LIMITED
Popular Stocks
BETA DRUGS LIMITED News
FAQs on BETA DRUGS LIMITED
What is the BETA DRUGS LIMITED share price today?
BETA DRUGS LIMITED share price is ₹ 1,770.00 as on 05 May, 2025 | 19:52 IST
What is today’s high & low share price of BETA DRUGS LIMITED?
BETA DRUGS LIMITED share price high: ₹ 1,785.00 and low: ₹ 1,752.05 as on 05 May, 2025 | 19:52 IST
What is the BETA DRUGS LIMITED share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 2,215.30 and Low Price is ₹ 1,047.65 as on 05 May, 2025 | 19:52 IST
What is the BETA DRUGS LIMITED Stock Symbol?
The BETA DRUGS LIMITED Stock symbol is BETA.
Can I buy BETA DRUGS LIMITED shares on Holidays?
No, shares of BETA DRUGS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BETA DRUGS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.